Övünç Okyay

Övünç Okyay has a diverse range of work experience in various industries. Övünç started their career as an Associate at McKinsey & Company in 2006, where they worked until 2008. Subsequently, they joined Morgan Stanley as an Equity Research Associate from 2010 to 2011.

In 2011, Övünç became an Advisor and later a Senior Associate at The Carlyle Group's Carlyle MENA Partners fund, focusing on mid-market growth investments in healthcare, education, and retail sectors. During their time with The Carlyle Group, they were involved in investments such as Medical Park.

In 2015, Övünç co-founded and served as the Vice President of IIG Istanbul Investment Group, an independent private equity firm that invests in mid-market growth and buyout opportunities in Turkey.

Since 2017, Övünç has been involved in several ventures. Övünç is the Managing Director of LG Capital AG, a venture builder and early-stage investor. Övünç is also a Co-Founder and Board Member of Spiden, a company developing medical technologies for personalized diagnostics. Additionally, Övünç co-founded and sits on the board of Caeli Nova, which focuses on developing products to improve human oxygenation in critical situations for commercial aviation, military, and healthcare applications.

Övünç Okyay has an extensive education history. Övünç pursued their Bachelor's degree in Mechanical Engineering at Boğaziçi University from 1999 to 2003. Following that, from 2003 to 2006, they enrolled at Technische Universität Berlin and completed their Master's degree in Production Engineering. Övünç furthered their education by attending Columbia Business School from 2009 to 2010, where they obtained their Master's in Business Administration (MBA) with a focus on Finance and Private Equity. Additionally, they attended Izmir Fen Lisesi from 1996 to 1999, although no specific degree or field of study was provided for this period.